| |
|
|
| Name: |
Simplify Asset Management Inc. |
| City: |
NY |
| State: |
NY |
| Zip: |
10018 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
21 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
PAGP |
Plains Gp Holdings Lp |
3 |
- |
$18.46 |
$21,889,000 |
1,372,360 |
3.39% |
-233,000 |
0 |
0.745 |
Oil & Gas Pipelines &... |
|
|
APLT |
Applied Therapeutics Inc. |
6 |
- |
$0.00 |
$8,099,000 |
2,417,505 |
1.26% |
2,079,000 |
0 |
5.035 |
N/A |
|
|
TCRX |
Tscan Therapeutics, Inc. |
10 |
- |
$0.00 |
$6,104,000 |
1,046,916 |
0.95% |
3,424,000 |
0 |
5.623 |
N/A |
|
|
CRNX |
Crinetics Pharmaceuticals, ... |
13 |
- |
$48.00 |
$4,092,000 |
115,000 |
0.63% |
672,000 |
0 |
0.198 |
N/A |
|
|
ATHA |
Athira Pharma, Inc. |
15 |
- |
$0.00 |
$3,627,000 |
1,492,792 |
0.56% |
612,000 |
0 |
4.844 |
N/A |
|
|
MDGL |
Madrigal Pharmaceuticals Inc |
19 |
- |
$205.25 |
$3,307,000 |
14,294 |
0.51% |
1,220,000 |
0 |
0.086 |
Diagnostic Substances |
|
|
DAWN |
Day One Biopharmaceuticals,... |
25 |
- |
$0.00 |
$2,555,000 |
175,018 |
0.4% |
408,000 |
0 |
0.283 |
N/A |
|
|
PHAT |
Phathom Pharmaceuticals, Inc. |
32 |
- |
$0.00 |
$2,172,000 |
237,935 |
0.34% |
-295,000 |
0 |
0.697 |
N/A |
|
|
BSV |
Vanguard Short-Term Bond |
34 |
- |
$76.21 |
$2,134,000 |
27,712 |
0.33% |
56,000 |
0 |
0.005 |
Closed - End Fund - E... |
|
|
MIRM |
Mirum Pharmaceuticals, Inc. |
36 |
- |
$0.00 |
$2,066,000 |
70,000 |
0.32% |
-146,000 |
0 |
0.19 |
N/A |
|
|
MRNS |
Marinus Pharmaceuticals Inc |
45 |
- |
$1.33 |
$1,631,000 |
150,000 |
0.25% |
423,000 |
0 |
0.302 |
N/A |
|
|
AKRO |
Akero Therapeutics, Inc. |
48 |
- |
$0.00 |
$1,396,000 |
59,777 |
0.22% |
-1,628,000 |
0 |
0.119 |
N/A |
|
|
KYN |
Kayne Anderson Mlp Investme... |
55 |
- |
$9.83 |
$1,259,000 |
147,033 |
0.2% |
22,000 |
0 |
0.116 |
Closed - End Fund - Debt |
|
|
KURA |
Kura Oncology Inc |
57 |
- |
$20.71 |
$1,150,000 |
80,000 |
0.18% |
420,000 |
0 |
0.105 |
N/A |
|
|
RNA |
Avidity Biosciences, Inc. |
58 |
- |
$25.96 |
$1,131,000 |
125,000 |
0.18% |
333,000 |
0 |
0.157 |
N/A |
|
|
KYMR |
Kymera Therapeutics, Inc. |
65 |
- |
$0.00 |
$777,000 |
30,515 |
0.12% |
353,000 |
0 |
0.051 |
N/A |
|
|
STRO |
Sutro Biopharma Inc |
76 |
- |
$4.15 |
$515,000 |
120,000 |
0.08% |
99,000 |
0 |
0.213 |
N/A |
|
|
CEE |
Central European Equity Fun... |
82 |
- |
$9.91 |
$380,000 |
38,957 |
0.06% |
45,000 |
0 |
0.539 |
Closed - End Fund - F... |
|
|
XFOR |
X4 Pharmaceuticals Inc |
83 |
- |
$1.05 |
$335,000 |
400,000 |
0.05% |
-101,000 |
0 |
0.578 |
N/A |
|
|
FLRN |
Spdr Barclays Investment Gr... |
88 |
- |
$30.76 |
$283,000 |
9,267 |
0.04% |
-2,000 |
0 |
0.012 |
N/A |
|
|
CYBN |
Cybin Inc |
98 |
- |
$0.36 |
$205,000 |
500,000 |
0.03% |
-61,000 |
0 |
0.315 |
N/A |
|
